GBP5 Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy

Pre-operative (neoadjuvant) or post-operative (adjuvant) taxane-based chemotherapy is still commonly used to treat patients with triple-negative breast cancer (TNBC). However, there are still no effective biomarkers used to predict the responsiveness and efficacy of taxane-based chemotherapy in TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shun-Wen, Chen, Po-Chih, Ger, Tzong-Rong, Chiu, Hui-Wen, Lin, Yuan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001168/
https://www.ncbi.nlm.nih.gov/pubmed/33809079
http://dx.doi.org/10.3390/jpm11030197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001168/
https://www.ncbi.nlm.nih.gov/pubmed/33809079
http://dx.doi.org/10.3390/jpm11030197

Ejemplares similares